If you and your doctor have decided that HUMIRA is the right treatment for your moderate to severe Crohn’s disease, you should know that HUMIRA comes with resources to help.
With HUMIRA Complete, answers to
your questions, treatment resources,
prescription savings, and encouragement
are ready for you when you need them.
Once enrolled, you’ll be connected with
your own Nurse Ambassador,* whose first
priority will be to help you start and stay on
track with your treatment plan as prescribed.
*Nurse Ambassadors do not give medical advice and will direct you to your health care professional for any treatment-related questions, including further referrals.
If your doctor decides that you are able to give your injections at home, you should receive training by a health care professional on the right way to prepare and inject HUMIRA. Do not try to inject HUMIRA yourself until you have been shown the right way to give the injections. Your first injection must be given under the supervision of a health care professional.
HUMIRA offers the independence of self-administration. You may not have to schedule an appointment in order to take your medication at a doctor's office, because you can take HUMIRA in the comfort of your home. HUMIRA is typically taken every other week, after an initial starting dose, and requires refrigeration until administration. Your doctor will follow up with you on a regular basis. Refer to the Patient Instructions for Use for the HUMIRA Pen or the prefilled syringe and the Medication Guide for more information.
Common side effects of HUMIRA include injection site reactions (redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away.
The chart below explains a standard HUMIRA dosing schedule. Always follow your doctor's instructions about when and how often to take HUMIRA.
For tips on how to properly inject HUMIRA, refer to the Patient Instructions for Use for the HUMIRA Pen or the prefilled syringe and the Medication Guide for more information. If you need additional help with self-injecting, you can view an instructional video here.
Important: You must pay attention to your starting dose—it is different than your maintenance dose and is a critical part of taking HUMIRA as prescribed. Your first injection must be given under the supervision of a health care professional. Remember to keep your HUMIRA refrigerated in its original container until ready for use.
4 HUMIRA Pens
2 HUMIRA Pens
*First dose can be administered as 4 injections in 1 day or as 2 injections per day for 2 consecutive days.
Note: Also available in prefilled syringe.
and every other week thereafter
1 HUMIRA Pen
On Day 29 you will begin your regularly scheduled dose of 1 HUMIRA® Pen (40 mg) every other week.
Remember, HUMIRA is a treatment, not a cure. If you’re feeling better after taking HUMIRA, that’s great. Do not stop taking HUMIRA unless your doctor tells you to stop. Some patients taking HUMIRA may think they can stop their treatment and still experience fewer Crohn's flares. Only your doctor can tell you if and when you should stop taking HUMIRA.
If you experience any adverse reactions or discomfort when taking HUMIRA, discuss them with your doctor right away.
You should discuss the potential benefits and risks of HUMIRA with your doctor. HUMIRA is a TNF blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is okay.
Serious infections have happened in people taking HUMIRA. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. Your doctor should test you for TB before starting HUMIRA, and check you closely for signs and symptoms of TB during treatment with HUMIRA, even if your TB test was negative. If your doctor feels you are at risk, you may be treated with medicine for TB.
Cancer. For children and adults taking TNF blockers, including HUMIRA, the chance of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers including HUMIRA, your chance of getting two types of skin cancer (basal cell and squamous cell) may increase. These types are generally not life-threatening if treated; tell your doctor if you have a bump or open sore that doesn’t heal.
Tell your doctor about all of your health conditions, including if you:
Also tell your doctor about all the medicines you take. You should not take HUMIRA with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab), ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab). Tell your doctor if you have ever used RITUXAN® (rituximab), IMURAN® (azathioprine), or PURINETHOL® (mercaptopurine, 6-MP).
HUMIRA can cause serious side effects, including:
Call your doctor or get medical care right away if you develop any of the above symptoms.
Common side effects of HUMIRA include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away.
HUMIRA is given by injection under the skin.
HUMIRA is a prescription medicine used:
HUMIRA is a prescription medicine used to reduce signs and symptoms, and to achieve and maintain clinical remission in adults with moderate to severe Crohn’s disease who have not responded well to conventional treatments. HUMIRA is also used to reduce signs and symptoms and achieve clinical remission in these adults who have also lost response to or are unable to tolerate infliximab.
Serious infections have happened in people taking HUMIRA. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. HUMIRA may increase the chance of getting lymphoma, including a rare kind, or other cancers. HUMIRA can cause serious side effects including hepatitis B infection in carriers of the virus, allergic reactions, nervous system problems, blood problems, heart failure, certain immune reactions including a lupus-like syndrome, liver problems, and new or worsening psoriasis.